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mpg.de (S. Deswal), schamel@immunbio.mpg.de (W.WThe T-cell antigen receptor (TCR) is a multisubunit transmembrane complex that mediates the anti-
gen-speciﬁc activation of T cells. Using a variety of techniques, several research groups have shown
that TCRs are at least partially pre-clustered before antigen binding. These new ﬁndings are contra-
dictory to the ‘‘classical” view, according to which TCRs are randomly distributed on the cell surface
and only associate upon antigen binding. In this review we try to answer the following questions:
What are the experimental evidences for the existence of pre-clustered TCRs? How can the TCR
pre-clusters be activated upon antigen binding?Which functional consequences for T-cell activation
arise from the pre-clustering of TCRs.
 2010 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
The antigen receptor of T cells (TCR) has a critical role in the rec-
ognition of antigen, the initiation of signaling events determining
T-cell fate, and providing immunity or tolerance. The ligand of
the abTCR is a composite surface of a peptide bound to a major his-
tocompatibility complex molecule (pMHC) on the surface of an
antigen presenting cell (for helper T cells) or a target cell (for cyto-
toxic T cells) [1]. The TCR binds to foreign peptides on MHC with
moderate afﬁnity (1–50 lM), resulting in phosphorylation of the
TCR and other signaling molecules triggering T-cell activation. In
contrast, the afﬁnity of the TCR to self peptide-MHC is lower, and
such engagement does not stimulate the T cell, thereby avoiding
autoimmunity [2]. To understand how the TCR can distinguish be-
tween different ligands, it is crucial to study its structure and the
molecular mechanisms through which it transmits the information
of antigen binding into the cell. Unfortunately, the three dimen-
sional molecular structure of the complete TCR is not known. How-chemical Societies. Published by E
ar Immunology, Max Planck-
ogy III, Faculty of Biology,
Germany.
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.A. Schamel).ever, biochemical and imaging studies have provided insight into
the organization of the TCR on the cell surface. On resting T cells,
the TCR is not randomly distributed in the plasma membrane,
but forms multimeric structures. In this review, we discuss how
the models for the distribution of the TCR on the T cell surface be-
fore antigen binding have changed, along with the development of
microscopic and biochemical techniques. We discuss how TCR acti-
vation in pre-clusters might happen, and the biological conse-
quences of TCR cluster formation.
2. The subunit composition of the TCR
The TCR complex consists of distinct type I transmembrane
polypeptide chains for antigen recognition and for transmitting
the information to the intracellular signaling molecules. The TCRa
and TCRb chains each contain a clonotypic variable immunoglobu-
lin (Ig) domain, which together form the antigen-binding site, in
addition to a constant Ig domain in each chain. Potentially posi-
tively charged transmembrane segments connect these extracellu-
lar domains to the short intracellular tails (Fig. 1a). The signaling
chains are the CD3ce and CD3de heterodimers and the ff homodi-
mer. Each CD3 subunit has an extracellular Ig domain followed by
a stalk region, whereas the extracellular part of f consists of only
nine amino acid residues. The transmembrane regions of the sig-
naling chains are potentially negatively charged (Fig. 1a). In their
intracellular tails the CD3 subunits contain one, whereas f contains

















Fig. 1. The T-cell antigen receptor. (a) In its minimal form the TCR is comprised of eight subunits: the clonotypic TCRab dimer, the CD3ed, CD3ec hetero-, and the ff
homodimers. The ectodomains of TCRa, TCRb, CD3e, CD3c and CD3d contain immunoglobulin domains (depicetd with oval shapes), while f has a very short ectodomain. In
addition, the stalk regions of the CD3 subunits are shown. All transmembrane regions are potentially charged, contributing to the assembly of the complex. The intracellular
part of the TCRab is very short, whereas each CD3 subunit has one, and f has three ITAMs. In addition, CD3e contains a proline-rich sequence (PRS). The TRIM homodimer,
which is a dispensable part of the TCR, is loosely associated. (b) The putative structure of the TCR from the top view according to Kuhns et al. [10]. The CD3 dimers are situated
in tandem orientation on one side of the TCRab dimer, whereas ff is located on the other side.
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an additional proline-rich sequence (PRS). To form the complete
TCR, the invariant CD3 and f subunits associate with the TCRab
chains via the transmembrane regions [4,5]. In addition, the Ig do-
mains of CD3 were shown to interact with the Ig domains of TCRab
[6].
For biochemical analyses, the TCR is extracted from the mem-
brane with detergents. This procedure might disrupt weak associ-
ations, especially those taking place within the membrane. The
minimal stoichiometry of the TCR complex extracted by detergents
is abcedeff [4,7,8], although one report suggested a (ab)2cedeff
composition [9]. Using mutagenesis and an erythropoietin recep-
tor-based proximity assay, it was shown that CD3 heterodimers
are docked in tandem orientation on one side of the TCR (Fig. 1b)
[6,10].
The TCRa, TCRb, CD3c, CD3d, CD3e and f chains are sufﬁcient to
express the TCR on the surface of non-T cells, indicating that they
are able to form a properly folded and assembled receptor complex
[11]. In T cells, a dimer of the TCR interacting molecule (TRIM) is
also part of the receptor complex (Fig. 1a). However, it is not
known what percentage of TCRs contain TRIM. TRIM-deﬁcient
mice produce a functional, surface-expressed TCR, demonstrating
that TRIM is dispensable for a functional TCR in vivo [12].
3. TCR clustering upon ligand engagement
For the initiation of T-cell activation, sustained TCR/pMHC
engagement is necessary. It has not been easy to mechanisticallyTCR
a b
Fig. 2. Models of the TCR distribution in the plasma membrane of resting T cells. (a) The
random collisions a small proportion might touch each other in a given moment. (b) TC
formed by strong protein–protein interactions and thus are very stable. (c) TCRs are no
domains leads to dynamic associations.explain how this happens, given the low amount of MHCmolecules
displaying the cognate peptide on the surface of an APC, and the
short half-life of the TCR–pMHC interaction (t1/2  15–0.1 s).
Receptor oligomerization upon ligand engagement plays a role in
the initiation of the signaling of several membrane receptors (e.g.
the EGFR family [13]), and this mechanism was similarly proposed
for the TCR. This model requires that the TCRs are individually ex-
pressed on the cell surface (Fig. 2a). The fact that soluble oligo-
meric, but not monomeric, pMHC activates the TCR makes it
probable that TCR oligomerization is a prerequisite for signal initi-
ation [14,15]. In the two dozen structures of complexes between
the ectodomains of TCRab and soluble pMHC, no dimers could be
observed [16]. The same holds true for the ectodomains of TCRab
alone. However, the complete TCR in its native membrane-bound
environment was not studied, thus these data do not resolve
whether the native TCR forms dimers or oligomers before or after
pMHC binding.
Ligand binding-induced TCR dimerization was studied using the
soluble extracellular parts of TCRab and pMHC; again not repre-
senting the membrane-bound complete TCR. Based on light scat-
tering measurements, it was suggested that the ectodomains of
the TCRab from murine 2B4 T cells oligomerize in solution and
form supramolecular structures following pMHC binding [17]. It
was proposed that, at limiting antigen concentrations, preferential
oligomerization of speciﬁc TCRab-pMHC complexes occurs on the
cell surface, thus maintaining T-cell sensitivity for low-abundance
ligands. Surface plasmon resonance measurements using the solu-
ble TCR fragment of mouse OT-1 T cells and its ligand showed thatc
TCR is randomly distributed, and does not form stable pre-clusters. However, due to
Rs coexist in pre-clustered and monomeric forms. The pre-clustered complexes are
n-randomly distributed on the cell surface. TCR enrichment in certain membrane
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dimerization [18]. However, these results could not be repeated
using the human A6 TCR, suggesting that the multimerization of
soluble TCR/pMHC complexes is not a general phenomenon [19].
These controversies suggested that the multimerization of the
TCR preceeding or following antigen binding should be better stud-
ied on the cell surface, using fully assembled TCRs.
The development of microscopy indeed had a great impact on
our understanding of the mechanism of T-cell activation. It was
discovered more than two decades ago that T cells form long-lived
cell–cell contacts with APCs and this process required the speciﬁc
TCR–pMHC interaction [20]. Using immunoﬂuorescence micros-
copy, it was shown that TCR redistributes on the cell surface and
accumulates at the contact zone with the APC, forming the immu-
nological synapse [20]. Within the synapse, signaling and adhesion
molecules form supramolecular activaton clusters (SMACs) [21].
Real-time imaging revealed that the TCR/pMHC complexes accu-
mulate in the outer ring of the synapse at the initiation of the T
cell–APC interaction and migrate to the center of the SMAC [22].
After pMHC binding, TCR forms microclusters 300–800 nm in
diameter, containing approximately 20–70 receptors. Signaling is
initiated in these supramolecular organizations, which also contain
the tyrosine kinase ZAP70 and the adaptor protein SLP-76. As
microclusters migrate toward the central SMAC (c-SMAC), signal-
ing terminates and ZAP70 and SLP-76 dissociate [23,24]. These
studies show that speciﬁc pMHC binding induces TCR microcluster
formation, but due to technical limitations small TCR clusters (few-
er than 20 receptors) could not be detected. In the following chap-
ters we will focus on the TCR pre-clusters that are smaller in size
than the activation-induced microclusters and whose organization
is independent of pMHC recognition.4. Preformed TCR clusters on non-activated T cells
It was shown that in cells expressing two TCRs with different
speciﬁcities, stimulation of one TCR resulted in the internalization
of the other. This was the ﬁrst experimental indication, albeit not
direct evidence, of physical association of at least two TCRabs
[25]. Further analysis of naïve, resting T cells from double trans-
genic mice expressing two different TCRs showed that at least a
fraction of the TCRs might be multivalent, i.e. contain two anti-
gen-binding TCRab dimers in one pre-formed cluster [9]: The
two different TCRbs could be co-immunoprecipitated [9]. An En-
doH digest of the carbohydrate groups prooved that these TCRs
had passed the Golgi complex, indicating that they were correctly
assembled TCRs and not misfolded proteins from the endoplasmic
reticulum. Co-puriﬁcation of two distinguishable TCRs was also ob-
served in a study using Jurkat transfectants [8]. Fluorescence reso-
nance energy transfer (FRET) between the two TCRs on living T
cells from the double transgenic mice conﬁrmed this result [9].
On this basis, Antonio de la Hera and Balbino Alarcon’s groups
demonstrated for the ﬁrst time that two antigen-recognizing
TCRab heterodimers associate in at least some of the TCRs on the
surface of resting primary T cells [9].
Further evidence for TCR pre-clusters on the surface of non-acti-
vated T cells was provided using biochemical techniques and elec-
tron microscopy [8]. Using Blue Native PAGE of detergent-
extracted TCRs from resting, primary T cells as well as from T cell
lines, higher-ordered complexes could be detected. In addition,
monovalent receptors were also present. The pre-clustered TCRs
were most likely dimers and multimers of the basic abcedeff stoi-
chiometry and did not contain comparable amounts of other sur-
face proteins. Multimeric forms of detergent-extracted TCRs were
also observed in other studies [26]. According to immuno-gold
labeling for electron microscopy, more than 55% of the TCRs wereorganized in oligomeric complexes, the majority of which were
found to bind two or three and a small proportion bound four or
more anti-CD3e-speciﬁc gold particles [8]. However, due to the
low staining efﬁciency of the immuno-gold labeling, and the par-
tial disruption of TCR oligomers by detergents used for the bio-
chemical analysis, the extent of TCR multimerization could be
underestimated.
Recently, modern microscopic techniques have allowed imag-
ing the surface of T cells with even better resolution. Using high-
speed photoactivated localization microscopy (hsPALM), molecules
can be located with a mean accuracy of 25 nm. Using this tech-
nique, it was shown that, on the surface of live T cells on non-acti-
vating ﬂuid lipid bilayers, TCRs form islands of 70–140 nm
diameter, containing 7–30 molecules each [27]. On bilayers con-
taining pMHC, the protein islands coalesce, so that 5–15 islands
form clusters, which have a size comparable to the previously dis-
cussed activation-induced microclusters observed earlier [23,24].
These results were also conﬁrmed by immuno-gold electron
microscopy [27].
Using two-color coincidence detection (TCCD) to deﬁne the self-
association quotient of TCRs, it was found that the TCR is present
on the cell surface mostly in monovalent form [28]. On the other
hand, the self-association quotient is greater than zero, suggesting
that some TCRs are pre-associated. In a related study, a signiﬁcant
portion of TCRs (10%) were found to be associated, using the dy-
namic single-molecule co-localization (DySCo) method [29]. How-
ever, the cells used in these experiments expressed 10-fold less
TCR than normal T cells. This difference in concentration might re-
sult in a dramatic change in dynamic associations, thus underesti-
mating the number of pre-clustered receptors in cell expressing
physiological levels of the TCR.5. The formation of TCR pre-clusters
Although plenty of evidence demonstrates that TCRs are not
randomly distributed on the cell surface (see above), the driving
force of TCR pre-clustering is not known. In a study using immu-
no-gold electron microscopy, the pre-clustered TCR complexes
were found predominantly as linear structures [8], suggesting
speciﬁc protein–protein interactions between two TCRs rather
than random associations (Fig. 2b). However, in a second study,
larger non-linear assemblies, (‘‘protein islands”) were detected
(Fig. 2c) [27]. As opposed to electron microscopy, which requires
ﬁxed samples for imaging, ﬂuorescence microscopy techniques
can provide information about the dynamics of the TCR clusters.
Using dual-color ﬂuorescence cross-correlation spectroscopy
(dcFCCS) to study diffusion, TCRs were found to be highly mobile
in the cell membrane (diffusion coefﬁcient D = 0.5 lm2/s). This
ﬁnding suggests that the positionally stable islands observed by
hsPALM do not result from strong protein–protein interactions,
but from either weak protein–protein interactions or from the
fact that the proteins are localized in a common membrane do-
main [27]. Indeed, TCR pre-clusters were shown to be sensitive
to the cholesterol content of the plasma membrane [8]. In other
studies, the TCRs had lower mobility (between D = 0.1 and
0.05 lm2/s) [28,30,31] with a fraction of immobile receptors
(D < 0.02 lm2/s) [30]. These differences could be attributed to
the different T cells used or to different temperatures (37 C
[28] and room temperature [30,31]) at which the experiments
were conducted.
If the TCRs do not form stable oligomers based on strong pro-
tein–protein interactions, but rather cluster as a result of co-local-
ization in small regions of the cell surface, the term ‘‘oligomer”
might be misleading and the use of ‘‘pre-formed assemblies or
clusters” is more appropriate.
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The existence of pre-clustered TCRs in resting cells (Fig. 2b and
c) questions the importance of antigen-induced clustering in TCR
triggering. Several models of receptor activation upon antigen
binding can be applied to the TCR. However, there are only two
models that do not exclude a role for pre-formed TCR clusters:
the segregation model and the conformational change model.
However, in principal both models would also be compatible with
individually expressed TCRs (Fig. 2a).
The segregation model explains TCR phosphorylation by anti-
gen binding-induced spatial separation of the TCR from phospha-
tases based on the size differences of the molecules [32]. TCR
and pMHC molecules are relatively small (both have a 7 nm long
ectodomain), and the cell membranes of the T cell and the APC or
target cell have to come close to allow engagement. The larger
phosphatases (e.g. CD45) are thus excluded from the contact zones,
where TCR becomes phosphorylated by kinases. This model is sup-
ported by ﬁndings that increasing the distance of the pMHC mole-
cules from the plasma membrane leads to inefﬁcient TCR
activation, since in this case the phosphatases do not segregate
from the TCR-pMHC contact zone [33].
On the other hand, according to the conformational change
model, antigen binding induces structural rearrangement within
the TCR complex, including the cytoplasmic tails of CD3, leading
to TCR phosphorylation [34]. The ﬁrst evidence for ligand-induced
conformational changes in the TCR complex was the exposure of
the proline-rich sequence in the cytoplasmic tail of the CD3e upon
dimeric ligand binding [35,36]. Consequently, it was proposed that
bivalent binding of pMHC to two TCRs changes their respective ori-
entation towards each other, resulting in CD3 rearrangements and
receptor activation status (permissive geometry model) [35]
(Fig. 3).
Besides this scenario, two other possible mechanisms of how
antigen binding of TCRab leads to conformational changes in CD3
were recently published. First, a structural rearrangement in the





Fig. 3. The permissive geometry model for TCR activation. (a) The pre-clustered
TCRs are in a closed conformation, which prevents phosphorylation by the
associated kinase. (b) Binding of bi- or multivalent ligands reorients TCRs in a
way that induces structural rearrangements in the cytoplasmic tails, allowing the
ITAMs to be phosphorylated.TCRab upon binding of pMHC [37]. From the AB loop, this stuctural
change could spread to the CD3 subunits. However, this model
does not explain why dimeric antigen binding is needed for T-cell
activation. Furthermore, it has recently been shown that the CD3
dimers are situated on the opposite side of the TCRab from the
AB loop, and that the AB loop is likely to have a role in TCR dimer-
ization upon triggering [10]. Second, a point mutation in the stalk
region of CD3e prevented the ligand-induced conformational
change in CD3, suggesting that ligand binding to the ectodomains
of CD3 leads to a stiffening of the CD3 structure including the cyto-
plasmic tails [38]. In agreement with the ﬁnding that the confor-
mational change is required for TCR activation [35], the CD3e
mutant inhibited signaling through the TCR. Interestingly, the mu-
tant CD3ewas also able to inhibit signaling via the wild type CD3e,
although it was expressed in much lower levels. This dominant ef-
fect can be explained, by a model involving TCR pre-clusters, such
that one mutant CD3e inhibits signaling via all TCRs within the
pre-cluster [38].7. Functional consequences of TCR pre-clustering
The existence of TCR pre-clusters on resting cells is by now well
established, but their role in T-cell triggering has to be further
investigated.
According to theoretical calculations, the co-expression of
monomeric and pre-clustered receptors provides the cell not only
with high sensitivity, but also the ability to respond over a broad
range of ligand concentration [39]. In line with this, it was found
that at low antigen concentrations, only pre-clustered TCRs are
phosphorylated, whereas at high antigen concentrations both
TCR monomers and pre-clusters become phosphorylated [8]. This
ﬁnding explains how pre-clustered receptors could be responsible
for the high sensitivity of the T cell to low ligand concentrations
[2], whereas monomeric receptors are responsible for distinguish-
ing among different high concentrations upon saturation of the
pre-clustered receptors. It was suggested that previously bound
and dissociated pMHC can rapidly rebind to another TCR of the
same pre-cluster, but not to more distant TCRs, which explains
the higher sensitivity of pre-clustered TCRs with respect to mono-
mers [40]. The on-rate of pMHC to a monomeric TCR is much lower
than that to a pre-cluster. Thus, the same pMHC concentration
stimulates fewer TCRs during a given time period in the monomer
compared to the pre-clustered TCR. Rapid rebinding of pMHC to
TCRs are the central claim of the serial triggering model [41].
Hence, pre-clustering enhances the avidity of the receptor–ligand
interaction, whereas the afﬁnity of the individual TCR-pMHC inter-
action is the same in TCR monomers and pre-clusters. Afﬁnity is
deﬁned as the energy of binding of one receptor to one ligand,
whereas avidity is the energy of binding between multiple recep-
tors and multiple ligands.
The effect of increased avidity on the T-cell response can be ob-
served using different cells expressing the same TCR. Activated T
cells bind pMHC tetramers better than the corresponding naïve T
cells [42]. The mathematical analysis of the TCR-pMHC binding
data showed that the increased binding was due to higher cluster-
ing rather than to an increased intrinsic dissociation constant [42].
This effect is cholesterol-dependent, since cholesterol depletion
decreased tetramer binding [42], as it was also shown to reduce
the extent of TCR multimerization [8]. Since the MHC molecules
on the antigen presenting cell were also shown to be multimeric
[43], the avidity of pre-clustered TCRs to pMHC clusters is higher
than individual afﬁnities of TCRs to MHCs. Indeed, disruption of
MHC pre-clusters on the presenting cell decreased the activation
of T cells [44]. This effect was more pronounced at low antigen
densities, which also indicates that pre-clustering of MHC and
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observations highlight the importance of testing the pre-clustering
state of TCR and pMHC for experiments using T cells and APCs, as
variations in this parameter inﬂuence the outcome of T-cell
stimulation.
If antigen binding to one receptor leads to the phosphorylation
of all receptors in the cluster, this would further increase the sen-
sitivity of pre-clustered TCRs [45]. This theory is supported by the
above-mentioned study, which shows that a small amount of a
mutant, inactive CD3e can inhibit signaling via the complete pre-
cluster [38]. Such cooperativity between the cytoplasmic tails of
the TCRs enables T cells to detect small relative changes in the
afﬁnity of pMHC in order to distinguish between foreign peptides
(moderate afﬁnity) or self-peptides (low afﬁnity) loaded on MHC
molecules [45].
The fact that dimeric engagement is necessary to trigger the
TCR [14] enforces the stringency for T-cell activation, hence play-
ing another role in discrimination between pMHC ligands with
different afﬁnities. Similar to the requirement of double phosphor-
ylation for activation of kinases in the MAP kinase pathway [46],
the need for dimeric binding for triggering offers a mechanism to
avoid spurious T-cell activation.8. Conclusions
Full understanding of how pMHC binding translates to TCR
phosphorylation, and how T cells discriminate between foreign
and self-peptides presented on the MHC molecules is still out of
our reach. However, ﬂuorescence microscopy techniques, bio-
chemical methods, protein crystallography and mathematical
modelling give us better insight into the molecular mechanisms
behind TCR triggering. The newly deﬁned organization of the TCR
on the surface of naïve T cells might be important not only for sig-
nal initiation, but also for the sensitivity of T cells and their capa-
bility to discriminate between antigens. To the arising questions,
such as how the TCR is directed in the milieu, where it forms pro-
tein islands, what is the driving force of cluster formation, or how
is the amount of the clusters in the T cell is regulated, we expect
answers from further technical-methodological developments.
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